Gerald William Smetana, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Perioperative Care | 15 | 2018 | 1002 | 2.810 |
Why?
|
| Teaching Rounds | 9 | 2023 | 253 | 2.790 |
Why?
|
| Lung Diseases | 12 | 2016 | 1886 | 1.520 |
Why?
|
| Practice Guidelines as Topic | 16 | 2021 | 7279 | 1.140 |
Why?
|
| Preoperative Care | 10 | 2015 | 2250 | 1.080 |
Why?
|
| Postoperative Complications | 19 | 2017 | 15295 | 0.920 |
Why?
|
| Drugs, Investigational | 3 | 2010 | 214 | 0.910 |
Why?
|
| Early Detection of Cancer | 3 | 2019 | 3086 | 0.690 |
Why?
|
| Asymptomatic Diseases | 3 | 2017 | 551 | 0.680 |
Why?
|
| Prostatic Hyperplasia | 1 | 2023 | 523 | 0.670 |
Why?
|
| Guideline Adherence | 4 | 2019 | 2266 | 0.660 |
Why?
|
| Cannabinoids | 1 | 2021 | 166 | 0.640 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2022 | 3255 | 0.630 |
Why?
|
| Diabetic Neuropathies | 1 | 2021 | 400 | 0.590 |
Why?
|
| Drug Approval | 2 | 2016 | 742 | 0.570 |
Why?
|
| Triamterene | 1 | 2016 | 4 | 0.560 |
Why?
|
| Mass Screening | 3 | 2017 | 5255 | 0.550 |
Why?
|
| Risk Assessment | 21 | 2022 | 23338 | 0.550 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2013 | 194 | 0.520 |
Why?
|
| Hypogonadism | 1 | 2021 | 799 | 0.510 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2018 | 386 | 0.510 |
Why?
|
| Urinalysis | 2 | 2015 | 369 | 0.490 |
Why?
|
| Hematocrit | 1 | 2015 | 636 | 0.470 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2013 | 29 | 0.460 |
Why?
|
| Respiratory Function Tests | 3 | 2015 | 1616 | 0.460 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2020 | 3047 | 0.430 |
Why?
|
| Anti-Obesity Agents | 1 | 2016 | 217 | 0.430 |
Why?
|
| Thyroxine | 1 | 2016 | 667 | 0.430 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2016 | 1240 | 0.420 |
Why?
|
| Heart Diseases | 3 | 2016 | 2788 | 0.420 |
Why?
|
| Cardiovascular Diseases | 10 | 2022 | 15165 | 0.410 |
Why?
|
| Potassium | 1 | 2016 | 1336 | 0.400 |
Why?
|
| Hypertension | 4 | 2018 | 8480 | 0.390 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.390 |
Why?
|
| Hypothyroidism | 1 | 2016 | 658 | 0.390 |
Why?
|
| Prediabetic State | 1 | 2016 | 499 | 0.390 |
Why?
|
| Anticoagulants | 4 | 2016 | 4599 | 0.380 |
Why?
|
| Bone Density Conservation Agents | 1 | 2018 | 773 | 0.380 |
Why?
|
| Testosterone | 1 | 2021 | 2420 | 0.380 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 745 | 0.370 |
Why?
|
| Pleural Cavity | 1 | 2010 | 22 | 0.370 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2012 | 214 | 0.360 |
Why?
|
| Drug Therapy | 1 | 2013 | 497 | 0.360 |
Why?
|
| Carotid Stenosis | 1 | 2017 | 854 | 0.360 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 336 | 0.360 |
Why?
|
| Patient Care | 1 | 2015 | 640 | 0.350 |
Why?
|
| Paracentesis | 1 | 2010 | 95 | 0.350 |
Why?
|
| Primary Health Care | 4 | 2015 | 4558 | 0.350 |
Why?
|
| Blood Pressure | 2 | 2018 | 8554 | 0.350 |
Why?
|
| Humans | 76 | 2023 | 744343 | 0.340 |
Why?
|
| Prostate-Specific Antigen | 1 | 2019 | 2494 | 0.340 |
Why?
|
| Atrial Fibrillation | 4 | 2019 | 5034 | 0.340 |
Why?
|
| Bariatric Surgery | 2 | 2017 | 952 | 0.340 |
Why?
|
| Surgical Procedures, Operative | 7 | 2017 | 1876 | 0.340 |
Why?
|
| Antihypertensive Agents | 3 | 2018 | 2046 | 0.340 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2013 | 454 | 0.330 |
Why?
|
| Family Practice | 2 | 2013 | 516 | 0.330 |
Why?
|
| Clinical Medicine | 1 | 2010 | 147 | 0.320 |
Why?
|
| Weight Loss | 2 | 2017 | 2622 | 0.310 |
Why?
|
| Exercise Test | 1 | 2015 | 2074 | 0.310 |
Why?
|
| Genetic Testing | 1 | 2020 | 3444 | 0.300 |
Why?
|
| Patient Selection | 1 | 2019 | 4215 | 0.300 |
Why?
|
| Hypercalcemia | 1 | 2010 | 409 | 0.300 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 2872 | 0.290 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2018 | 3068 | 0.280 |
Why?
|
| Electrocardiography | 3 | 2016 | 6442 | 0.280 |
Why?
|
| Pneumothorax | 1 | 2010 | 379 | 0.280 |
Why?
|
| Cholesterol | 1 | 2015 | 2917 | 0.280 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 1213 | 0.280 |
Why?
|
| Risk Factors | 19 | 2022 | 72290 | 0.270 |
Why?
|
| Internal Medicine | 4 | 2019 | 1009 | 0.270 |
Why?
|
| Respiratory Insufficiency | 4 | 2006 | 1199 | 0.260 |
Why?
|
| Aged | 18 | 2023 | 163280 | 0.250 |
Why?
|
| Formularies as Topic | 1 | 2004 | 91 | 0.240 |
Why?
|
| Drainage | 1 | 2010 | 1142 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 11725 | 0.240 |
Why?
|
| Radiography | 1 | 2015 | 7023 | 0.240 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2010 | 269 | 0.240 |
Why?
|
| Electroconvulsive Therapy | 1 | 2009 | 477 | 0.230 |
Why?
|
| Clinical Competence | 3 | 2015 | 4687 | 0.230 |
Why?
|
| Patient Care Team | 1 | 2014 | 2531 | 0.220 |
Why?
|
| Cardiology | 5 | 2015 | 1668 | 0.220 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2023 | 174 | 0.220 |
Why?
|
| Warfarin | 1 | 2011 | 1496 | 0.210 |
Why?
|
| Specialization | 1 | 2007 | 777 | 0.200 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2023 | 107 | 0.200 |
Why?
|
| Hemorrhage | 1 | 2013 | 3461 | 0.200 |
Why?
|
| Obesity | 4 | 2019 | 12745 | 0.190 |
Why?
|
| Oxidoreductases | 1 | 2023 | 424 | 0.190 |
Why?
|
| Medical History Taking | 2 | 2002 | 783 | 0.180 |
Why?
|
| Heart Failure | 1 | 2023 | 10900 | 0.180 |
Why?
|
| Spirometry | 3 | 2009 | 864 | 0.170 |
Why?
|
| Drug Therapy, Combination | 3 | 2023 | 6489 | 0.170 |
Why?
|
| Psoas Abscess | 1 | 1999 | 9 | 0.170 |
Why?
|
| Ticlopidine | 2 | 2018 | 899 | 0.170 |
Why?
|
| Bone and Bones | 1 | 2010 | 2575 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 20129 | 0.170 |
Why?
|
| Fusobacterium Infections | 1 | 1999 | 53 | 0.160 |
Why?
|
| Headache Disorders | 1 | 2000 | 130 | 0.160 |
Why?
|
| Medicine | 1 | 2007 | 946 | 0.160 |
Why?
|
| United States | 11 | 2022 | 69872 | 0.160 |
Why?
|
| Patients | 1 | 2004 | 900 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2023 | 63114 | 0.150 |
Why?
|
| Giant Cell Arteritis | 1 | 2002 | 292 | 0.150 |
Why?
|
| Fusobacterium nucleatum | 1 | 1999 | 162 | 0.150 |
Why?
|
| Acute Coronary Syndrome | 1 | 2011 | 2337 | 0.150 |
Why?
|
| Gender Identity | 1 | 2023 | 688 | 0.150 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 1105 | 0.150 |
Why?
|
| Alendronate | 1 | 2018 | 171 | 0.150 |
Why?
|
| Male | 16 | 2023 | 350118 | 0.150 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2003 | 783 | 0.140 |
Why?
|
| Referral and Consultation | 2 | 2020 | 3528 | 0.140 |
Why?
|
| Genetic Counseling | 1 | 2020 | 600 | 0.140 |
Why?
|
| Primary Prevention | 2 | 2022 | 1167 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 11124 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 6487 | 0.140 |
Why?
|
| Smoking Cessation | 3 | 2014 | 2071 | 0.140 |
Why?
|
| Coffee | 1 | 2020 | 578 | 0.140 |
Why?
|
| Female | 16 | 2023 | 380194 | 0.140 |
Why?
|
| Echocardiography, Stress | 1 | 2016 | 131 | 0.130 |
Why?
|
| Methods | 1 | 2015 | 1129 | 0.130 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 2541 | 0.130 |
Why?
|
| Age Factors | 5 | 2014 | 18370 | 0.130 |
Why?
|
| Pain | 1 | 2010 | 4986 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 8037 | 0.120 |
Why?
|
| Urology | 1 | 2019 | 399 | 0.120 |
Why?
|
| Risk Reduction Behavior | 3 | 2015 | 1125 | 0.120 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2017 | 503 | 0.120 |
Why?
|
| Postoperative Care | 4 | 2009 | 1486 | 0.120 |
Why?
|
| Intraoperative Care | 2 | 2009 | 767 | 0.120 |
Why?
|
| Clonidine | 1 | 2014 | 164 | 0.120 |
Why?
|
| Analgesics | 1 | 2021 | 1040 | 0.120 |
Why?
|
| Diet, Reducing | 1 | 2017 | 462 | 0.120 |
Why?
|
| Preoperative Period | 1 | 2016 | 549 | 0.120 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 11727 | 0.120 |
Why?
|
| Arizona | 1 | 2013 | 108 | 0.110 |
Why?
|
| Diphosphonates | 1 | 2018 | 623 | 0.110 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 1150 | 0.110 |
Why?
|
| Quality of Health Care | 3 | 2009 | 4371 | 0.110 |
Why?
|
| Osteoporotic Fractures | 1 | 2018 | 401 | 0.110 |
Why?
|
| Infant, Newborn | 2 | 2023 | 25625 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2017 | 952 | 0.110 |
Why?
|
| Benchmarking | 2 | 2009 | 1042 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 2356 | 0.110 |
Why?
|
| Diuretics | 1 | 2016 | 592 | 0.110 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12959 | 0.110 |
Why?
|
| Endarterectomy, Carotid | 1 | 2017 | 546 | 0.110 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2012 | 92 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2019 | 861 | 0.100 |
Why?
|
| Absorptiometry, Photon | 1 | 2018 | 1725 | 0.100 |
Why?
|
| Middle Aged | 10 | 2019 | 213383 | 0.100 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2017 | 1813 | 0.100 |
Why?
|
| Hospitalization | 1 | 2011 | 10262 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2020 | 3610 | 0.100 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 3670 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 20822 | 0.100 |
Why?
|
| Smoking | 3 | 2020 | 8987 | 0.100 |
Why?
|
| Cooperative Behavior | 2 | 2012 | 1504 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2023 | 5007 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13102 | 0.090 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 924 | 0.090 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 554 | 0.090 |
Why?
|
| Exercise Therapy | 1 | 2017 | 906 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4933 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 2 | 2011 | 1537 | 0.090 |
Why?
|
| Breast | 1 | 2018 | 1969 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 15076 | 0.090 |
Why?
|
| Drug-Eluting Stents | 2 | 2017 | 753 | 0.080 |
Why?
|
| Systole | 1 | 2011 | 958 | 0.080 |
Why?
|
| Diastole | 1 | 2011 | 791 | 0.080 |
Why?
|
| Adult | 9 | 2021 | 214055 | 0.080 |
Why?
|
| Hypercholesterolemia | 1 | 2015 | 1151 | 0.080 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 634 | 0.070 |
Why?
|
| Mammography | 1 | 2018 | 2476 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2009 | 9849 | 0.070 |
Why?
|
| Quinoxalines | 1 | 2008 | 290 | 0.070 |
Why?
|
| Radiation Dosage | 1 | 2015 | 1928 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 3 | 2006 | 738 | 0.070 |
Why?
|
| Benzazepines | 1 | 2008 | 326 | 0.070 |
Why?
|
| Blood Transfusion | 1 | 2013 | 1301 | 0.070 |
Why?
|
| Thiophenes | 1 | 2011 | 588 | 0.070 |
Why?
|
| Heart Function Tests | 1 | 2007 | 330 | 0.070 |
Why?
|
| Patient Participation | 1 | 2015 | 1457 | 0.070 |
Why?
|
| Drug Costs | 1 | 2013 | 1105 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 1405 | 0.070 |
Why?
|
| Bone Density | 1 | 2018 | 3468 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2013 | 1573 | 0.060 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2009 | 546 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2014 | 1470 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2017 | 3748 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2017 | 5985 | 0.060 |
Why?
|
| Aspirin | 2 | 2018 | 3282 | 0.060 |
Why?
|
| Health Policy | 1 | 2016 | 2661 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2971 | 0.060 |
Why?
|
| Health Expenditures | 1 | 2016 | 2348 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2014 | 2149 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2011 | 1873 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 9959 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2016 | 3209 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2009 | 3537 | 0.050 |
Why?
|
| Curriculum | 1 | 2015 | 3605 | 0.050 |
Why?
|
| Venous Thromboembolism | 1 | 2014 | 1671 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2009 | 1171 | 0.050 |
Why?
|
| Colectomy | 1 | 2007 | 683 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 3507 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2009 | 1184 | 0.050 |
Why?
|
| Hematologic Tests | 1 | 2003 | 240 | 0.050 |
Why?
|
| Telephone | 1 | 2004 | 617 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2003 | 528 | 0.050 |
Why?
|
| Blood Sedimentation | 1 | 2002 | 231 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 1432 | 0.050 |
Why?
|
| Health Services Misuse | 1 | 2003 | 243 | 0.050 |
Why?
|
| Comorbidity | 2 | 2007 | 10388 | 0.050 |
Why?
|
| Kidney Function Tests | 1 | 2003 | 684 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 5391 | 0.050 |
Why?
|
| Piperazines | 1 | 2011 | 2488 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2006 | 986 | 0.050 |
Why?
|
| Cluster Headache | 1 | 2000 | 54 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2017 | 12720 | 0.040 |
Why?
|
| Tension-Type Headache | 1 | 2000 | 77 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2015 | 3445 | 0.040 |
Why?
|
| Managed Care Programs | 1 | 2004 | 950 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2004 | 1681 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2006 | 1198 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13284 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2009 | 3743 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 57776 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 1239 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 2004 | 1071 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2003 | 1265 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2017 | 256 | 0.030 |
Why?
|
| Sex Factors | 1 | 2010 | 10397 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2002 | 1011 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2010 | 6077 | 0.030 |
Why?
|
| Physical Examination | 1 | 2002 | 1237 | 0.030 |
Why?
|
| Delirium | 1 | 2006 | 1609 | 0.030 |
Why?
|
| Stroke | 1 | 2017 | 9981 | 0.030 |
Why?
|
| Risk | 1 | 2007 | 9687 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2009 | 3046 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2002 | 1181 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 2017 | 486 | 0.030 |
Why?
|
| Decision Making | 1 | 2007 | 3887 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2017 | 693 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 681 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2009 | 5027 | 0.030 |
Why?
|
| Analgesia | 2 | 2006 | 461 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 4644 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2004 | 3229 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12245 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 29063 | 0.020 |
Why?
|
| Biopsy | 1 | 2002 | 6756 | 0.020 |
Why?
|
| Health Status | 1 | 2003 | 4034 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 950 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 19905 | 0.020 |
Why?
|
| Migraine Disorders | 1 | 2000 | 1620 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2017 | 1643 | 0.020 |
Why?
|
| Lung | 1 | 2006 | 9856 | 0.020 |
Why?
|
| Low Back Pain | 1 | 2016 | 956 | 0.020 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 1390 | 0.020 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 1164 | 0.020 |
Why?
|
| Anesthesia | 2 | 2006 | 1561 | 0.020 |
Why?
|
| American Heart Association | 1 | 2009 | 1056 | 0.020 |
Why?
|
| Asthma | 1 | 2003 | 6011 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1972 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2004 | 40561 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10638 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 2208 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2004 | 53288 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 3923 | 0.010 |
Why?
|
| Mentors | 1 | 2002 | 631 | 0.010 |
Why?
|
| Clinical Clerkship | 1 | 2002 | 532 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 168757 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2006 | 2151 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2002 | 2759 | 0.010 |
Why?
|